Carasent

Q3 2026 highlights

• Net sales amounted to SEK 108.2 (82.2) million, corresponding to a net sales growth of 32%.
• Organic growth amounted to 12% at constant currency.
• EBITDA amounted to SEK 27.5 (23.6) million, corresponding to an EBITDA margin of 25% (29%).
• Adjusted EBITDA margin amounted to 25% (29%).
• EBITDAC margin amounted to 20% (15%).
• Operating result amounted to SEK 9.1 (7.2) million.
• Cash flow from operating activities amounted to SEK 5.5 (2.5) million.
• Profit after tax amounted to SEK 10.3 (14.1) million.
• Earnings per share, before and after dilution, amounted to SEK 0.15 (0.20).

January–September 2026 highlights

• Net sales amounted to SEK 296.3 (250.3) million, corresponding to a net sales growth of 18%.
• Organic growth amounted to 10% at constant currency.
• EBITDA amounted to SEK 60.5 (49.6) million, corresponding to an EBITDA margin of 20% (20%).
• Adjusted EBITDA margin amounted to 22% (20%).
• Adjusted EBITDAC margin amounted to 14% (8%).
• Operating result amounted to SEK 8.1 (1.7) million.
• Cash flow from operating activities amounted to SEK 73.7 (19.8) million.
• Profit after tax amounted to SEK 10.5 (5.6) million.
• Earnings per share, before and after dilution, amounted to SEK 0.15 (0.08).

Carasent will present its interim report via a webcast and conference call at 08:00 CET today. Use the link below to join the webcast.
Carasent Q3 Report 2026

For further information, please contact:
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493